dc.creator | Teruya-Gibu, Alberto A. | |
dc.creator | Ortiz-Guerra, Percy | |
dc.creator | Arzapalo-Poma, Abad A. | |
dc.date.accessioned | 2023-11-30T01:22:00Z | |
dc.date.accessioned | 2024-05-09T19:18:13Z | |
dc.date.available | 2023-11-30T01:22:00Z | |
dc.date.available | 2024-05-09T19:18:13Z | |
dc.date.created | 2023-11-30T01:22:00Z | |
dc.date.issued | 2023-09-28 | |
dc.identifier | Revista Peruana de Medicina Experimental y Salud Pública. 2023; 40(3). | |
dc.identifier | https://hdl.handle.net/20.500.12959/4617 | |
dc.identifier | https://doi.org/10.17843/rpmesp.2023.403.12572 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/9391334 | |
dc.description.abstract | La vacunación contra el SARS-CoV-2 no está exenta de efectos adversos. Se presenta dos casos de afecta-ción endocrina asociada a la vacunación por la COVID-19. Mujer de 46 años que, luego de la primera do-sis, presentó fiebre persistente y signos de tirotoxicosis, tras el diagnóstico de tiroiditis subaguda asociada a vacunación por la COVID-19, el cuadro remitió con el uso de corticoides. Varón de 71 años, que luego de la vacunación por la COVID-19, presentó hipoglicemias hiperinsulinemicas, con resultado positivo de anticuerpos antiinsulina. Se le diagnosticó con una hipoglicemia autoinmune asociada a la vacunación por la COVID-19 y recibió tratamiento con prednisona, controlando los episodios de hipoglicemia. En conclusión, las enfermedades endocrinas asociadas a vacunación por la COVID-19 son extremadamente raras y su detección oportuna permite su tratamiento adecuado. | |
dc.description.abstract | SARS-CoV-2 vaccination is not free of adverse effects. We present two cases of endocrine involvement associated with COVID-19 vaccination. A 46-year-old woman who, after receiving the first COVID-19 vaccination dose, presented persistent fever and signs of thyrotoxicosis after being diagnosed with suba-cute thyroiditis associated with COVID-19 vaccination; the condition remitted with the use of corticoids. A 71-year-old male, who after COVID-19 vaccination, presented hyperinsulinemic hypoglycemia, testing positive for anti-insulin antibodies; he was diagnosed with autoimmune hypoglycemia associated with COVID-19 vaccination and received treatment with prednisone, controlling the episodes of hypoglyce-mia. In conclusion, endocrine diseases associated with COVID-19 vaccination are extremely rare and their timely detection allows adequate treatment. | |
dc.language | spa | |
dc.publisher | Instituto Nacional de Salud | |
dc.relation | https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/12572 | |
dc.rights | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Tiroiditis Subaguda | |
dc.subject | Hipoglicemia Autoinmune | |
dc.subject | Covid-19 | |
dc.subject | Vacunación | |
dc.subject | Subacute Thyroiditis | |
dc.subject | Autoimmune | |
dc.subject | Hypoglycemia | |
dc.subject | Vaccination | |
dc.title | Enfermedades endocrinas asociadas a vacunación por la covid-19: reporte de casos | |
dc.type | info:eu-repo/semantics/article | |